[dhimes]

A little off-topic, but part of the problem with personalized medicine I think is that the target market for any drug developed for a particular personalization is necessarily small. In other words, right now it is a bad business decision. Perhaps it can be used as a delta- to a mass-market drug in the future, like seasonings to a basic recipe, but that's a bit off.

[anon1253]

Perhaps, but not sure if it's the correct explanation for https://en.wikipedia.org/wiki/Eroom's_law

I think the focus on data-driven pipelines for discovery, rather than focus on fundamental understanding of the biology and chemistry of organisms might also play a role. But I have no "proof" to back that up, other than my anecdotal experience as a researcher in a genetics institute :p